Cargando…
Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2
The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptoms of COVID-19 can range from asymptomatic to severe, which could lead to fatality. Like other pathogenic viruses, the infection of SARS-CoV-2 relies on binding its spike glycopro...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486761/ https://www.ncbi.nlm.nih.gov/pubmed/36125525 http://dx.doi.org/10.1007/s00449-022-02788-8 |
_version_ | 1784792348703588352 |
---|---|
author | Khan, Mohammad Mansoob Goh, Yea-Wen Ahmad, Norhayati Siddique, Monowarul Mobin |
author_facet | Khan, Mohammad Mansoob Goh, Yea-Wen Ahmad, Norhayati Siddique, Monowarul Mobin |
author_sort | Khan, Mohammad Mansoob |
collection | PubMed |
description | The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptoms of COVID-19 can range from asymptomatic to severe, which could lead to fatality. Like other pathogenic viruses, the infection of SARS-CoV-2 relies on binding its spike glycoprotein to the host receptor angiotensin-converting enzyme 2 (ACE 2). Molecular studies suggested that there is a high affinity between the spike glycoprotein and ACE 2 that might arise due to their hydrophobic interaction. This property is mainly responsible for making this virus highly infectious. Apart from this, the transmissibility of the virus, prolonged viability in certain circumstances, and rapid mutations also contributed to the current pandemic situation. Nanotechnology provides potential alternative solutions to combat COVID-19 with the development of i. nanomaterial-based COVID-19 detection technology, ii. nanomaterial-based disinfectants, iii. nanoparticle-based vaccines, and iv. nanoparticle-based drug delivery. Hence, this review provides diverse insight into understanding COVID-19. |
format | Online Article Text |
id | pubmed-9486761 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-94867612022-09-21 Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2 Khan, Mohammad Mansoob Goh, Yea-Wen Ahmad, Norhayati Siddique, Monowarul Mobin Bioprocess Biosyst Eng Critical Review The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptoms of COVID-19 can range from asymptomatic to severe, which could lead to fatality. Like other pathogenic viruses, the infection of SARS-CoV-2 relies on binding its spike glycoprotein to the host receptor angiotensin-converting enzyme 2 (ACE 2). Molecular studies suggested that there is a high affinity between the spike glycoprotein and ACE 2 that might arise due to their hydrophobic interaction. This property is mainly responsible for making this virus highly infectious. Apart from this, the transmissibility of the virus, prolonged viability in certain circumstances, and rapid mutations also contributed to the current pandemic situation. Nanotechnology provides potential alternative solutions to combat COVID-19 with the development of i. nanomaterial-based COVID-19 detection technology, ii. nanomaterial-based disinfectants, iii. nanoparticle-based vaccines, and iv. nanoparticle-based drug delivery. Hence, this review provides diverse insight into understanding COVID-19. Springer Berlin Heidelberg 2022-09-20 2022 /pmc/articles/PMC9486761/ /pubmed/36125525 http://dx.doi.org/10.1007/s00449-022-02788-8 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Critical Review Khan, Mohammad Mansoob Goh, Yea-Wen Ahmad, Norhayati Siddique, Monowarul Mobin Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2 |
title | Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2 |
title_full | Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2 |
title_fullStr | Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2 |
title_full_unstemmed | Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2 |
title_short | Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2 |
title_sort | understanding and combating covid-19 using the biology and chemistry of sars-cov-2 |
topic | Critical Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486761/ https://www.ncbi.nlm.nih.gov/pubmed/36125525 http://dx.doi.org/10.1007/s00449-022-02788-8 |
work_keys_str_mv | AT khanmohammadmansoob understandingandcombatingcovid19usingthebiologyandchemistryofsarscov2 AT gohyeawen understandingandcombatingcovid19usingthebiologyandchemistryofsarscov2 AT ahmadnorhayati understandingandcombatingcovid19usingthebiologyandchemistryofsarscov2 AT siddiquemonowarulmobin understandingandcombatingcovid19usingthebiologyandchemistryofsarscov2 |